Ascending and descending tracts of spinal cord add clinical significance drugs and blockers associated with it

| Feature | Detail |
|---|---|
| Location | Anterolateral white matter |
| Modalities | Pain, temperature, crude touch |
| 1st-order cell body | Dorsal root ganglion |
| Enters spinal cord | Posterior root → posterior horn |
| Synapse delay | Some fibers ascend 1-2 segments in Lissauer's tract before synapsing in laminae I & V |
| Crossing | 2nd-order axons cross obliquely over 2-3 segments via the anterior commissure (contralateral side) |
| 3rd-order relay | VPL nucleus of thalamus |
| Feature | Detail |
|---|---|
| Location | Posterior funiculus |
| Modalities | Fine/discriminative touch, vibration, conscious proprioception, 2-point discrimination |
| Subtracts | Fasciculus gracilis (lower limb/trunk, medial), Fasciculus cuneatus (upper limb/neck, lateral) |
| 1st-order relay | Ipsilateral ascent to caudal medulla → nucleus gracilis / nucleus cuneatus |
| Crossing | 2nd-order axons cross as internal arcuate fibers → form medial lemniscus in contralateral medulla |
| 3rd-order relay | VPL nucleus of thalamus |
| Tract | Input | Crossing | Target |
|---|---|---|---|
| Dorsal spinocerebellar | Lower limb proprioception | Does NOT cross (ipsilateral) | Cerebellum via inferior cerebellar peduncle |
| Ventral spinocerebellar | Lower limb proprioception | Crosses twice (net ipsilateral) | Cerebellum via superior cerebellar peduncle |
| Feature | Detail |
|---|---|
| Origin | Primary motor cortex (Betz cells, layer V) |
| Course | Corona radiata → posterior limb of internal capsule → crus cerebri → pons (small bundles) → medullary pyramid |
| Decussation | Pyramidal decussation at caudal medulla (~85-90% of fibers cross) |
| Location in cord | Lateral funiculus |
| Synapse | Lower motor neurons (LMN) in the lateral anterior horn |
| Function | Voluntary movement of limbs (especially fine distal movements) |
| Tract | Origin | Decussation | Function |
|---|---|---|---|
| Anterior corticospinal tract | Motor cortex (ipsilateral fibers that didn't decussate) | Crosses at segmental level; projects bilaterally | Axial/truncal muscles |
| Tectospinal tract | Superior colliculus (dorsal tegmental decussation) | Crosses immediately | Reflex postural movements in response to visual stimuli; head/neck only (cervical cord) |
| Vestibulospinal tracts | Lateral & medial vestibular nuclei | Lateral = ipsilateral, entire cord; Medial = bilateral, thoracic | Facilitates extensors/antigravity, inhibits flexors; maintains balance |
| Reticulospinal tracts | Pontine and medullary reticular formation | Ipsilateral | Regulates voluntary movements, reflex activity, autonomic outflow |
| Syndrome | Tracts Affected | Clinical Picture |
|---|---|---|
| Brown-Séquard (cord hemisection) | Ipsilateral LCST + dorsal columns; contralateral STT | Ipsilateral UMN weakness + ipsilateral loss of proprioception/vibration; contralateral pain/temp loss (1-2 levels below) |
| Anterior cord syndrome | Bilateral LCST + bilateral STT; dorsal columns spared | Bilateral UMN weakness + bilateral pain/temp loss; proprioception/vibration preserved |
| Central cord syndrome | Central crossing STT fibers; central LCST (cervical fibers most central) | Arms > legs weakness; bilateral loss of pain/temp at lesion level; bladder dysfunction |
| Posterior cord syndrome | Dorsal columns | Loss of proprioception/vibration; preserved pain/temp and motor |
| Subacute combined degeneration | Dorsal columns + LCST | Loss of proprioception + UMN signs; B12 deficiency |
| Syringomyelia | Anterior commissure (crossing STT fibers) | Bilateral suspended cape-like pain/temp loss; preserved dorsal columns early |
| Drug/Class | Mechanism | Target in Pathway |
|---|---|---|
| Opioids (morphine, fentanyl, oxycodone) | μ (mu) receptor agonists (Gi-coupled) | Dorsal horn (substantia gelatinosa, laminae I/II), PAG of spinomesencephalic tract; pre- and post-synaptic inhibition of pain transmission |
| Intrathecal/epidural opioids | Direct opioid receptor activation in dorsal horn | Blocks spinothalamic input at spinal level; dramatically reduces dose requirements |
| NSAIDs / COX inhibitors (ibuprofen, diclofenac) | Reduce prostaglandin sensitization of nociceptors | Peripheral sensitization of 1st-order neurons |
| Capsaicin | TRPV1 agonist → depletes Substance P | 1st-order nociceptive terminals; C-fiber desensitization |
| Gabapentin / Pregabalin | Block α2δ subunit of voltage-gated Ca²⁺ channels | Reduce glutamate/Substance P release from dorsal horn synapses |
| Amitriptyline / TCAs | Block norepinephrine/serotonin reuptake; Na+ channel block | Augment descending inhibitory pathways (reticulospinal) onto STT neurons |
| Ketamine | NMDA receptor antagonist | Blocks central sensitization ("wind-up") in dorsal horn |
| Substance P / NK1 receptor antagonists | Block tachykinin signaling | Laminae I/V interneurons of STT |
| Drug/Class | Mechanism |
|---|---|
| Opioids | Activate PAG (spinomesencephalic target) → activate descending noradrenergic and serotonergic inhibitory tracts that suppress dorsal horn |
| SNRIs (duloxetine, venlafaxine) | Block NE + 5-HT reuptake in descending inhibitory reticulospinal pathway |
| Tizanidine | α2-adrenoceptor agonist → inhibits noradrenergic descending excitation of spinal motor/pain circuits |
| Clonidine (intrathecal) | α2 agonist → pre-synaptic inhibition in dorsal horn; used for spinal analgesia |
| Drug/Class | Mechanism | Clinical use |
|---|---|---|
| Baclofen | GABA-B receptor agonist → hyperpolarizes motor interneurons; reduces presynaptic excitatory neurotransmitter release in spinal cord | Spasticity from spinal cord injury, MS, stroke |
| Intrathecal baclofen (ITB) | Direct delivery to spinal cord → very high local concentration at GABA-B receptors | Severe spasticity, dystonia |
| Diazepam / Benzodiazepines | GABA-A receptor modulator (increase Cl⁻ influx) → enhance presynaptic inhibition in spinal cord (α2-GABA-A receptors prominent here) | Spasticity; also reduces anxiety-related muscle tension |
| Tizanidine | α2-adrenoceptor agonist → inhibits excitatory interneurons in spinal cord | Spasticity (also analgesia - see above) |
| Dantrolene | Blocks ryanodine receptor → reduces Ca²⁺ release from sarcoplasmic reticulum | Acts directly on muscle (not on cord tracts per se), but used for spasticity |
| Botulinum toxin | Cleaves SNARE proteins → blocks ACh release at NMJ | Peripheral; treats focal spasticity |
| Drug | Mechanism | Tract Selectivity |
|---|---|---|
| Bupivacaine, ropivacaine, lidocaine | Block voltage-gated Na+ channels → prevent action potential propagation | Differential block: small unmyelinated C-fibers (STT-pain) blocked first at low concentration; large myelinated Aβ (dorsal column) and motor (CST) blocked only at high concentration. Allows spinal analgesia with partial motor preservation |
| Spinal (intrathecal) block | LA diffuses into CSF around nerve roots and spinal cord | Blocks all tracts at the level administered in a predictable dermatomal pattern |
| Epidural block | LA diffuses through dura, primarily acts on nerve roots | Segmental; at low concentration, selectively spares motor (CST) while blocking STT - exploited in labor analgesia |
| Tract | Modality | Lesion Effect | Key Drug/Blocker |
|---|---|---|---|
| Spinothalamic | Pain, temperature, crude touch | Contralateral loss (crosses in cord) | Opioids, ketamine, gabapentin, LA |
| Dorsal column (DCML) | Proprioception, vibration, fine touch | Ipsilateral loss (crosses in medulla) | B12 (for deficiency), SCS |
| Lateral corticospinal | Voluntary limb movement | Contralateral UMN weakness + spasticity | Baclofen, diazepam, tizanidine |
| Spinomesencephalic | Pain modulation via PAG | PAG opioid analgesia | Opioids (PAG activation) |
| Reticulospinal | Posture, reflexes, autonomic | Dysautonomia if damaged | SNRIs, tizanidine, clonidine |
| Spinocerebellar | Subconscious proprioception | Ipsilateral limb ataxia | None specific; treat underlying cause |
Create flowcharts only including ascending and descending tracts with syndromes and treatment
mkdir -p /home/daytona/workspace/spinal-tracts && ls /home/daytona/workspace/spi…
Failed to create session: bad request: failed to resolve container IP after 3 attempts: no IP address found. Is the Sandbox started?
We encountered an error while processing your request. Please try again or reach out to us for help.
Create flowcharts only including ascending and descending tracts with syndromes and treatment
mkdir -p /home/daytona/workspace/spinal-tracts && echo "dir ready"
~/spinal-tracts/ascending_tracts.html
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Ascending Tracts of the Spinal Cord</title>
<style>
* { box-sizing: border-box; margin: 0; padding: 0; }
body { font-family: 'Segoe UI', Arial, sans-serif; background: #f0f4f8; padding: 30px; }
h1 { text-align: center; color: #1a237e; font-size: 26px; margin-bottom: 6px; letter-spacing: 1px; }
.subtitle { text-align: center; color: #546e7a; font-size: 13px; margin-bottom: 30px; }
.flowchart-container { display: flex; gap: 24px; justify-content: center; flex-wrap: wrap; }
.tract-card {
background: white;
border-radius: 14px;
box-shadow: 0 4px 18px rgba(0,0,0,0.10);
width: 340px;
padding: 0 0 18px 0;
overflow: hidden;
}
.tract-header {
padding: 14px 18px;
color: white;
font-size: 15px;
font-weight: 700;
text-align: center;
border-radius: 14px 14px 0 0;
letter-spacing: 0.5px;
}
.sttt .tract-header { background: linear-gradient(135deg,#c62828,#e53935); }
.dcml .tract-header { background: linear-gradient(135deg,#1565c0,#1e88e5); }
.sc .tract-header { background: linear-gradient(135deg,#2e7d32,#43a047); }
.step {
margin: 10px 16px 0 16px;
border-radius: 8px;
padding: 9px 14px;
font-size: 12.5px;
position: relative;
}
.step-title { font-weight: 700; font-size: 12px; text-transform: uppercase; letter-spacing: 0.5px; margin-bottom: 2px; }
.step-body { color: #37474f; line-height: 1.5; }
.step-receptor { background: #fce4ec; border-left: 4px solid #e91e63; }
.step-1n { background: #fff3e0; border-left: 4px solid #ff9800; }
.step-cross { background: #ede7f6; border-left: 4px solid #7c4dff; }
.step-2n { background: #e8f5e9; border-left: 4px solid #4caf50; }
.step-thal { background: #e3f2fd; border-left: 4px solid #2196f3; }
.step-cortex { background: #e8eaf6; border-left: 4px solid #3f51b5; }
.arrow {
text-align: center;
font-size: 20px;
color: #90a4ae;
margin: 2px 0;
line-height: 1.2;
}
.clinical-box {
margin: 12px 16px 0 16px;
background: #fff8e1;
border: 1px solid #ffe082;
border-radius: 8px;
padding: 9px 13px;
}
.clinical-box .box-title {
font-weight: 700; font-size: 11.5px; color: #e65100; text-transform: uppercase; letter-spacing: 0.5px; margin-bottom: 5px;
}
.clinical-box ul { padding-left: 14px; }
.clinical-box li { font-size: 12px; color: #4e342e; margin-bottom: 3px; line-height: 1.4; }
.drug-box {
margin: 10px 16px 0 16px;
background: #e8f5e9;
border: 1px solid #a5d6a7;
border-radius: 8px;
padding: 9px 13px;
}
.drug-box .box-title {
font-weight: 700; font-size: 11.5px; color: #1b5e20; text-transform: uppercase; letter-spacing: 0.5px; margin-bottom: 5px;
}
.drug-box ul { padding-left: 14px; }
.drug-box li { font-size: 12px; color: #1b5e20; margin-bottom: 3px; line-height: 1.4; }
.lesion-tag {
display: inline-block;
background: #ef9a9a;
color: #b71c1c;
border-radius: 4px;
padding: 1px 7px;
font-size: 11px;
font-weight: 700;
margin-top: 3px;
}
.lesion-ipsi { background: #90caf9; color: #0d47a1; }
footer { text-align: center; margin-top: 30px; color: #90a4ae; font-size: 11px; }
</style>
</head>
<body>
<h1>ASCENDING TRACTS OF THE SPINAL CORD</h1>
<p class="subtitle">Pathway · Clinical Lesion Effects · Drugs & Blockers</p>
<div class="flowchart-container">
<!-- SPINOTHALAMIC TRACT -->
<div class="tract-card sttt">
<div class="tract-header">ANTEROLATERAL / SPINOTHALAMIC TRACT (STT)</div>
<div class="step step-receptor">
<div class="step-title">Receptor / Stimulus</div>
<div class="step-body">Pain, Temperature, Crude Touch<br>Free nerve endings, thermoreceptors</div>
</div>
<div class="arrow">↓</div>
<div class="step step-1n">
<div class="step-title">1st Order Neuron</div>
<div class="step-body">Cell body: <b>Dorsal Root Ganglion</b><br>
Enters cord via posterior root<br>
Some fibers ascend 1–2 segments in <b>Lissauer's Tract</b><br>
Synapses: Posterior horn laminae I & V</div>
</div>
<div class="arrow">↓</div>
<div class="step step-cross">
<div class="step-title">Decussation</div>
<div class="step-body"><b>Anterior commissure</b> — crosses within 2–3 spinal cord segments<br>
Joins <b>contralateral</b> anterolateral column</div>
</div>
<div class="arrow">↓</div>
<div class="step step-2n">
<div class="step-title">2nd Order Neuron</div>
<div class="step-body">Ascends in anterolateral white matter<br>
<b>Spinoreticular</b> → Reticular formation (emotional/arousal aspects of pain)<br>
<b>Spinomesencephalic</b> → PAG + Superior colliculus (central pain modulation)</div>
</div>
<div class="arrow">↓</div>
<div class="step step-thal">
<div class="step-title">3rd Order Neuron (Thalamus)</div>
<div class="step-body">VPL nucleus of thalamus</div>
</div>
<div class="arrow">↓</div>
<div class="step step-cortex">
<div class="step-title">Cortex</div>
<div class="step-body">Posterior limb of internal capsule → <b>Primary Somatosensory Cortex (S1)</b></div>
</div>
<div class="clinical-box">
<div class="box-title">⚠ Clinical Lesion Effects</div>
<ul>
<li><b>STT lesion</b> → <span class="lesion-tag">CONTRALATERAL</span> loss of pain & temperature below the lesion</li>
<li><b>Brown-Séquard (hemisection)</b>: Contralateral pain/temp loss (1–2 levels below)</li>
<li><b>Anterior cord syndrome</b>: Bilateral loss of pain/temp; preserved proprioception</li>
<li><b>Syringomyelia</b>: Bilateral "cape-like" pain/temp loss (anterior commissure damaged)</li>
<li><b>Cordotomy</b>: Surgical STT section for intractable cancer pain</li>
</ul>
</div>
<div class="drug-box">
<div class="box-title">💊 Drugs / Blockers</div>
<ul>
<li><b>Opioids</b> (morphine, fentanyl): μ-receptor agonists in dorsal horn & PAG</li>
<li><b>Gabapentin/Pregabalin</b>: Block α2δ Ca²⁺ channel subunit → ↓ Substance P release</li>
<li><b>Ketamine</b>: NMDA antagonist → blocks dorsal horn wind-up</li>
<li><b>Capsaicin</b>: TRPV1 agonist → depletes Substance P from C-fibers</li>
<li><b>Local Anesthetics</b> (bupivacaine): Block Na⁺ channels, C-fibers blocked first</li>
<li><b>NSAIDs/COX inhibitors</b>: Reduce prostaglandin sensitization of 1st-order neurons</li>
<li><b>Clonidine (intrathecal)</b>: α2 agonist → pre-synaptic inhibition at dorsal horn</li>
</ul>
</div>
</div>
<!-- DORSAL COLUMN / MEDIAL LEMNISCAL -->
<div class="tract-card dcml">
<div class="tract-header">DORSAL COLUMN – MEDIAL LEMNISCAL (DCML) PATHWAY</div>
<div class="step step-receptor">
<div class="step-title">Receptor / Stimulus</div>
<div class="step-body">Fine touch, Vibration, Conscious proprioception, 2-point discrimination<br>Meissner's, Pacinian corpuscles, Muscle spindles</div>
</div>
<div class="arrow">↓</div>
<div class="step step-1n">
<div class="step-title">1st Order Neuron</div>
<div class="step-body">Cell body: <b>Dorsal Root Ganglion</b><br>
Enters cord; <b>ascends ipsilaterally</b> in posterior funiculus:<br>
— <b>Fasciculus Gracilis</b> (medial): lower limb + trunk<br>
— <b>Fasciculus Cuneatus</b> (lateral): upper limb + neck<br>
Synapses at caudal medulla</div>
</div>
<div class="arrow">↓</div>
<div class="step step-cross">
<div class="step-title">Decussation (MEDULLA)</div>
<div class="step-body">Nucleus gracilis / Nucleus cuneatus<br>
2nd-order axons cross as <b>Internal Arcuate Fibers</b><br>
Form <b>Medial Lemniscus</b> in contralateral medulla</div>
</div>
<div class="arrow">↓</div>
<div class="step step-2n">
<div class="step-title">2nd Order Neuron</div>
<div class="step-body">Ascends through brainstem as Medial Lemniscus</div>
</div>
<div class="arrow">↓</div>
<div class="step step-thal">
<div class="step-title">3rd Order Neuron (Thalamus)</div>
<div class="step-body">VPL nucleus of thalamus</div>
</div>
<div class="arrow">↓</div>
<div class="step step-cortex">
<div class="step-title">Cortex</div>
<div class="step-body">Posterior limb of internal capsule → <b>Primary Somatosensory Cortex (S1)</b></div>
</div>
<div class="clinical-box">
<div class="box-title">⚠ Clinical Lesion Effects</div>
<ul>
<li><b>Dorsal column lesion</b> → <span class="lesion-tag lesion-ipsi">IPSILATERAL</span> loss of proprioception, vibration & fine touch</li>
<li><b>Brown-Séquard</b>: Ipsilateral proprioception/vibration loss</li>
<li><b>Posterior cord syndrome</b>: Isolated dorsal column; sensory ataxia</li>
<li><b>Subacute combined degeneration</b> (Vit B12 deficiency): Dorsal columns + LCST; Romberg +ve, UMN signs</li>
<li><b>Tabes dorsalis</b> (neurosyphilis): Dorsal column degeneration; lightning pains, Romberg +ve, Charcot joints</li>
<li>Tests: Tuning fork (vibration), Romberg test, 2-point discrimination</li>
</ul>
</div>
<div class="drug-box">
<div class="box-title">💊 Drugs / Neuromodulation</div>
<ul>
<li><b>Vitamin B12 (cyanocobalamin)</b>: Reverses subacute combined degeneration</li>
<li><b>Penicillin (high dose IV)</b>: Treats tabes dorsalis (neurosyphilis)</li>
<li><b>Spinal Cord Stimulation (SCS)</b>: Electrodes stimulate dorsal columns → "gate control" suppresses pain (STT)</li>
<li><b>Local Anesthetics</b>: High concentration needed to block large Aβ fibers (dorsal column type)</li>
</ul>
</div>
</div>
<!-- SPINOCEREBELLAR TRACTS -->
<div class="tract-card sc">
<div class="tract-header">SPINOCEREBELLAR TRACTS (Subconscious Proprioception)</div>
<div class="step step-receptor">
<div class="step-title">Receptor / Stimulus</div>
<div class="step-body">Muscle spindles, Golgi tendon organs, Joint receptors<br><b>Subconscious proprioception</b> (does NOT reach cortex)</div>
</div>
<div class="arrow">↓</div>
<div class="step step-1n">
<div class="step-title">Dorsal Spinocerebellar Tract (DSCT)</div>
<div class="step-body">Cell body: Clarke's nucleus (C8–L2)<br>
Carries lower limb proprioception<br>
<b>Does NOT cross</b> — ascends ipsilaterally in lateral funiculus<br>
→ Cerebellum via <b>inferior cerebellar peduncle</b></div>
</div>
<div class="arrow">↓</div>
<div class="step step-2n">
<div class="step-title">Ventral Spinocerebellar Tract (VSCT)</div>
<div class="step-body">Carries lower limb proprioception<br>
Crosses TWICE (net ipsilateral)<br>
→ Cerebellum via <b>superior cerebellar peduncle</b></div>
</div>
<div class="arrow">↓</div>
<div class="step step-cortex">
<div class="step-title">Target: Cerebellum</div>
<div class="step-body">Coordinates ipsilateral limb movements<br>Adjusts motor output for smooth, coordinated motion</div>
</div>
<div class="clinical-box">
<div class="box-title">⚠ Clinical Lesion Effects</div>
<ul>
<li><b>Spinocerebellar lesion</b> → <span class="lesion-tag lesion-ipsi">IPSILATERAL</span> limb ataxia, dysmetria, dysdiadochokinesis</li>
<li><b>Friedreich's Ataxia</b>: Loss of spinocerebellar tracts + dorsal columns + LCST; frataxin gene mutation; onset <25 yrs</li>
<li>Gait: Wide-based, staggering; falls to ipsilateral side</li>
<li>No sensory level (subconscious pathway)</li>
</ul>
</div>
<div class="drug-box">
<div class="box-title">💊 Treatment</div>
<ul>
<li><b>Friedreich's ataxia</b>: Omaveloxolone (Nrf2 activator, FDA 2023) — first approved therapy</li>
<li>Symptomatic: Physiotherapy, speech therapy, cardiac management (hypertrophic cardiomyopathy)</li>
<li>No specific tract-targeted pharmacology; treatment is disease-directed</li>
</ul>
</div>
</div>
</div>
<footer>Source: Gray's Anatomy for Students (Elsevier 2023) · Goodman & Gilman's · Katzung's Pharmacology</footer>
</body>
</html>
~/spinal-tracts/descending_tracts.html
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Descending Tracts of the Spinal Cord</title>
<style>
* { box-sizing: border-box; margin: 0; padding: 0; }
body { font-family: 'Segoe UI', Arial, sans-serif; background: #f0f4f8; padding: 30px; }
h1 { text-align: center; color: #1a237e; font-size: 26px; margin-bottom: 6px; letter-spacing: 1px; }
.subtitle { text-align: center; color: #546e7a; font-size: 13px; margin-bottom: 30px; }
.section-label {
text-align: center; font-size: 16px; font-weight: 700;
color: white; padding: 8px 20px; border-radius: 20px;
display: inline-block; margin: 0 auto 18px auto;
}
.lateral-label { background: #6a1b9a; }
.medial-label { background: #00695c; }
.section-wrap { text-align: center; margin-bottom: 12px; }
.flowchart-container { display: flex; gap: 20px; justify-content: center; flex-wrap: wrap; margin-bottom: 30px; }
.tract-card {
background: white; border-radius: 14px;
box-shadow: 0 4px 18px rgba(0,0,0,0.10);
width: 310px; padding: 0 0 16px 0; overflow: hidden;
}
.tract-card.wide { width: 360px; }
.tract-header {
padding: 12px 16px; color: white; font-size: 13.5px; font-weight: 700;
text-align: center; border-radius: 14px 14px 0 0; letter-spacing: 0.5px;
}
.lcst-h { background: linear-gradient(135deg,#6a1b9a,#8e24aa); }
.rubro-h { background: linear-gradient(135deg,#ad1457,#e91e63); }
.acst-h { background: linear-gradient(135deg,#1565c0,#1e88e5); }
.tecto-h { background: linear-gradient(135deg,#e65100,#ff9800); }
.vest-h { background: linear-gradient(135deg,#00695c,#00897b); }
.reti-h { background: linear-gradient(135deg,#2e7d32,#43a047); }
.step {
margin: 9px 14px 0 14px; border-radius: 7px;
padding: 8px 12px; font-size: 12px; position: relative;
}
.step-title { font-weight: 700; font-size: 11.5px; text-transform: uppercase; letter-spacing: 0.4px; margin-bottom: 2px; }
.step-body { color: #37474f; line-height: 1.45; }
.s-origin { background: #ede7f6; border-left: 4px solid #7c4dff; }
.s-cross { background: #fce4ec; border-left: 4px solid #e91e63; }
.s-loc { background: #fff3e0; border-left: 4px solid #ff9800; }
.s-synapse { background: #e8f5e9; border-left: 4px solid #4caf50; }
.s-func { background: #e3f2fd; border-left: 4px solid #2196f3; }
.arrow { text-align: center; font-size: 18px; color: #90a4ae; margin: 2px 0; }
.clinical-box {
margin: 10px 14px 0 14px; background: #fff8e1;
border: 1px solid #ffe082; border-radius: 7px; padding: 8px 12px;
}
.clinical-box .box-title { font-weight: 700; font-size: 11px; color: #e65100; text-transform: uppercase; letter-spacing: 0.4px; margin-bottom: 4px; }
.clinical-box ul { padding-left: 13px; }
.clinical-box li { font-size: 11.5px; color: #4e342e; margin-bottom: 3px; line-height: 1.4; }
.drug-box {
margin: 8px 14px 0 14px; background: #e8f5e9;
border: 1px solid #a5d6a7; border-radius: 7px; padding: 8px 12px;
}
.drug-box .box-title { font-weight: 700; font-size: 11px; color: #1b5e20; text-transform: uppercase; letter-spacing: 0.4px; margin-bottom: 4px; }
.drug-box ul { padding-left: 13px; }
.drug-box li { font-size: 11.5px; color: #1b5e20; margin-bottom: 3px; line-height: 1.4; }
.tag { display: inline-block; border-radius: 4px; padding: 1px 6px; font-size: 10.5px; font-weight: 700; margin-top: 2px; }
.tag-contra { background: #ef9a9a; color: #b71c1c; }
.tag-ipsi { background: #90caf9; color: #0d47a1; }
.tag-bilat { background: #c8e6c9; color: #1b5e20; }
.comparison-table { width: 100%; border-collapse: collapse; font-size: 12px; margin: 20px auto; max-width: 1100px; }
.comparison-table th { background: #1a237e; color: white; padding: 9px 12px; }
.comparison-table td { padding: 8px 12px; border: 1px solid #dee2e6; vertical-align: top; }
.comparison-table tr:nth-child(even) td { background: #f5f5f5; }
footer { text-align: center; margin-top: 24px; color: #90a4ae; font-size: 11px; }
</style>
</head>
<body>
<h1>DESCENDING TRACTS OF THE SPINAL CORD</h1>
<p class="subtitle">Pathway · Clinical Lesion Effects · Drugs & Blockers</p>
<!-- LATERAL MOTOR SYSTEM -->
<div class="section-wrap"><span class="section-label lateral-label">LATERAL MOTOR SYSTEM — Controls Limb Movements</span></div>
<div class="flowchart-container">
<!-- LATERAL CORTICOSPINAL TRACT -->
<div class="tract-card wide">
<div class="tract-header lcst-h">LATERAL CORTICOSPINAL TRACT (LCST) — Most Clinically Important</div>
<div class="step s-origin">
<div class="step-title">Origin</div>
<div class="step-body">Primary <b>Motor Cortex</b> — Betz cells (Layer V, precentral gyrus)</div>
</div>
<div class="arrow">↓</div>
<div class="step s-loc">
<div class="step-title">Descent Path</div>
<div class="step-body">Corona radiata → <b>Posterior limb of internal capsule</b> → Crus cerebri (midbrain) → Pons (small bundles) → <b>Medullary Pyramid</b></div>
</div>
<div class="arrow">↓</div>
<div class="step s-cross">
<div class="step-title">Decussation</div>
<div class="step-body"><b>Pyramidal decussation</b> at caudal medulla (~85–90% of fibers cross)<br>Joins <b>contralateral</b> lateral funiculus</div>
</div>
<div class="arrow">↓</div>
<div class="step s-synapse">
<div class="step-title">Synapse</div>
<div class="step-body">Lower Motor Neurons (LMN) in the <b>lateral anterior horn</b> (all cord levels)</div>
</div>
<div class="arrow">↓</div>
<div class="step s-func">
<div class="step-title">Function</div>
<div class="step-body">Voluntary movement of <b>limbs</b> (especially fine, skilled distal movements); finger dexterity</div>
</div>
<div class="clinical-box">
<div class="box-title">⚠ Clinical Lesion Effects</div>
<ul>
<li><b>UMN lesion</b> → <span class="tag tag-contra">CONTRALATERAL</span> spastic weakness, hyperreflexia, Babinski sign (extensor plantar)</li>
<li><b>In spinal cord</b>: <span class="tag tag-ipsi">IPSILATERAL</span> UMN weakness below lesion</li>
<li><b>Brown-Séquard</b>: Ipsilateral UMN spastic paralysis below lesion</li>
<li><b>Anterior cord syndrome</b>: Bilateral UMN weakness + bilateral pain/temp loss</li>
<li><b>ALS</b>: Combined UMN (LCST) + LMN (anterior horn) degeneration</li>
<li><b>Multiple Sclerosis</b>: Demyelination of LCST → spastic paraparesis</li>
<li>LMN lesion (anterior horn/nerve) → flaccid weakness, areflexia, wasting, fasciculations</li>
</ul>
</div>
<div class="drug-box">
<div class="box-title">💊 Drugs for UMN Spasticity (LCST damage)</div>
<ul>
<li><b>Baclofen</b>: GABA-B agonist → hyperpolarizes spinal interneurons; oral or intrathecal pump</li>
<li><b>Tizanidine</b>: α2-adrenoceptor agonist → inhibits excitatory interneurons in cord</li>
<li><b>Diazepam</b>: GABA-A modulator → presynaptic inhibition in spinal cord</li>
<li><b>Dantrolene</b>: Blocks ryanodine receptor → ↓ Ca²⁺ release from SR (direct muscle action)</li>
<li><b>Botulinum toxin A</b>: Cleaves SNARE → blocks ACh at NMJ (focal spasticity)</li>
<li><b>Intrathecal baclofen (ITB pump)</b>: For severe spasticity in SCI, MS, CP</li>
</ul>
</div>
</div>
<!-- RUBROSPINAL TRACT -->
<div class="tract-card">
<div class="tract-header rubro-h">RUBROSPINAL TRACT</div>
<div class="step s-origin">
<div class="step-title">Origin</div>
<div class="step-body"><b>Red nucleus</b> — Midbrain tegmentum</div>
</div>
<div class="arrow">↓</div>
<div class="step s-cross">
<div class="step-title">Decussation</div>
<div class="step-body"><b>Ventral tegmental decussation</b> — crosses immediately in midbrain</div>
</div>
<div class="arrow">↓</div>
<div class="step s-loc">
<div class="step-title">Location in Cord</div>
<div class="step-body">Lateral funiculus (with LCST)<br>Descends only to <b>cervical</b> cord</div>
</div>
<div class="arrow">↓</div>
<div class="step s-synapse">
<div class="step-title">Synapse</div>
<div class="step-body">Interneurons in anterior horn (cervical)</div>
</div>
<div class="arrow">↓</div>
<div class="step s-func">
<div class="step-title">Function</div>
<div class="step-body">Facilitates <b>flexor</b> + inhibits extensor muscles of upper limb<br>(Assists LCST; limited significance in humans)</div>
</div>
<div class="clinical-box">
<div class="box-title">⚠ Clinical Notes</div>
<ul>
<li>Minimal independent clinical role in humans</li>
<li>May provide partial motor recovery after LCST injury</li>
<li><span class="tag tag-contra">CONTRALATERAL</span> limb ataxia if red nucleus lesion (Claude's syndrome)</li>
</ul>
</div>
<div class="drug-box">
<div class="box-title">💊 Treatment</div>
<ul>
<li>No specific pharmacological target</li>
<li>Neurorehabilitation; physiotherapy for compensation</li>
</ul>
</div>
</div>
</div>
<!-- MEDIAL MOTOR SYSTEM -->
<div class="section-wrap"><span class="section-label medial-label">MEDIAL MOTOR SYSTEM — Controls Axial/Postural Muscles</span></div>
<div class="flowchart-container">
<!-- ANTERIOR CORTICOSPINAL TRACT -->
<div class="tract-card">
<div class="tract-header acst-h">ANTERIOR CORTICOSPINAL TRACT (ACST)</div>
<div class="step s-origin">
<div class="step-title">Origin</div>
<div class="step-body">Motor cortex — fibers that did NOT decussate at pyramids (~10–15%)</div>
</div>
<div class="arrow">↓</div>
<div class="step s-cross">
<div class="step-title">Decussation</div>
<div class="step-body">Crosses at each <b>segmental level</b>; projects <b>bilaterally</b></div>
</div>
<div class="arrow">↓</div>
<div class="step s-loc">
<div class="step-title">Location</div>
<div class="step-body">Medial anterior funiculus (upper thoracic cord)</div>
</div>
<div class="arrow">↓</div>
<div class="step s-func">
<div class="step-title">Function</div>
<div class="step-body">Controls <b>axial/truncal muscles</b> involved in posture and balance</div>
</div>
<div class="clinical-box">
<div class="box-title">⚠ Clinical Notes</div>
<ul>
<li>Bilateral projection → difficult to lateralize clinically</li>
<li>Trunk weakness in cord lesions</li>
<li><span class="tag tag-bilat">BILATERAL</span> pattern due to bilateral projections</li>
</ul>
</div>
<div class="drug-box">
<div class="box-title">💊 Treatment</div>
<ul>
<li>Same antispasticity agents as LCST lesions</li>
<li>Core strengthening physiotherapy</li>
</ul>
</div>
</div>
<!-- TECTOSPINAL TRACT -->
<div class="tract-card">
<div class="tract-header tecto-h">TECTOSPINAL TRACT</div>
<div class="step s-origin">
<div class="step-title">Origin</div>
<div class="step-body"><b>Superior colliculus</b> — dorsal midbrain (receives visual input)</div>
</div>
<div class="arrow">↓</div>
<div class="step s-cross">
<div class="step-title">Decussation</div>
<div class="step-body"><b>Dorsal tegmental decussation</b> in midbrain; projects bilaterally</div>
</div>
<div class="arrow">↓</div>
<div class="step s-loc">
<div class="step-title">Location</div>
<div class="step-body">Near anterior median fissure; <b>cervical cord only</b></div>
</div>
<div class="arrow">↓</div>
<div class="step s-func">
<div class="step-title">Function</div>
<div class="step-body">Reflex postural movements in response to <b>visual stimuli</b>; head/neck turning</div>
</div>
<div class="clinical-box">
<div class="box-title">⚠ Clinical Notes</div>
<ul>
<li>Limited clinical significance in isolation</li>
<li>Contributes to head-turning reflex toward visual targets</li>
<li>May be damaged in high cervical cord lesions</li>
</ul>
</div>
<div class="drug-box">
<div class="box-title">💊 Treatment</div>
<ul>
<li>No specific pharmacological target</li>
<li>Treat underlying midbrain/cervical pathology</li>
</ul>
</div>
</div>
<!-- VESTIBULOSPINAL TRACT -->
<div class="tract-card">
<div class="tract-header vest-h">VESTIBULOSPINAL TRACTS</div>
<div class="step s-origin">
<div class="step-title">Origin</div>
<div class="step-body">
<b>Lateral vestibular nucleus</b> → Lateral vestibulospinal tract (ipsilateral, entire cord)<br>
<b>Medial vestibular nucleus</b> → Medial vestibulospinal tract (bilateral, to thoracic cord)
</div>
</div>
<div class="arrow">↓</div>
<div class="step s-loc">
<div class="step-title">Location</div>
<div class="step-body">Anterior white matter; receives input from <b>inner ear + cerebellum</b></div>
</div>
<div class="arrow">↓</div>
<div class="step s-synapse">
<div class="step-title">Synapse</div>
<div class="step-body">Interneurons in anterior horn (ipsilateral)</div>
</div>
<div class="arrow">↓</div>
<div class="step s-func">
<div class="step-title">Function</div>
<div class="step-body"><b>Facilitates extensors/antigravity muscles</b>, inhibits flexors<br>Maintains balance and upright posture; anti-fall reflex</div>
</div>
<div class="clinical-box">
<div class="box-title">⚠ Clinical Lesion Effects</div>
<ul>
<li>Loss → postural instability, tendency to fall</li>
<li><b>Vestibular neuritis / labyrinthitis</b>: Impaired righting responses</li>
<li><b>Lateral medullary (Wallenberg) syndrome</b>: Damaged vestibular nuclei → vertigo, nystagmus, falling to ipsilateral side</li>
</ul>
</div>
<div class="drug-box">
<div class="box-title">💊 Drugs</div>
<ul>
<li><b>Betahistine</b>: Histamine H1 agonist/H3 antagonist → improves vestibular blood flow; used in Ménière's</li>
<li><b>Prochlorperazine</b>: D2 antagonist → reduces vertigo/nausea</li>
<li><b>Meclizine/Cinnarizine</b>: Antihistamines → suppress vestibular system</li>
</ul>
</div>
</div>
<!-- RETICULOSPINAL TRACT -->
<div class="tract-card">
<div class="tract-header reti-h">RETICULOSPINAL TRACTS</div>
<div class="step s-origin">
<div class="step-title">Origin</div>
<div class="step-body">
<b>Pontine (medial) reticulospinal</b>: Nucleus reticularis pontis<br>
<b>Medullary (lateral) reticulospinal</b>: Nucleus reticularis gigantocellularis
</div>
</div>
<div class="arrow">↓</div>
<div class="step s-loc">
<div class="step-title">Location</div>
<div class="step-body">Anterior white matter; descend ipsilaterally through entire cord</div>
</div>
<div class="arrow">↓</div>
<div class="step s-synapse">
<div class="step-title">Synapse</div>
<div class="step-body">Interneurons in anterior horn; autonomic neurons</div>
</div>
<div class="arrow">↓</div>
<div class="step s-func">
<div class="step-title">Function</div>
<div class="step-body">Regulates voluntary movements, reflex activity, <b>autonomic outflow</b>, gait; <b>descending pain inhibition</b> (serotonergic/noradrenergic fibers)</div>
</div>
<div class="clinical-box">
<div class="box-title">⚠ Clinical Lesion Effects</div>
<ul>
<li><b>Spinal cord injury</b>: Loss of descending autonomic control → <b>neurogenic bladder/bowel</b>, autonomic dysreflexia</li>
<li><b>Autonomic dysreflexia</b> (T6 and above): Hypertensive crisis from uninhibited sympathetic outflow</li>
<li>Loss of descending pain inhibition → central sensitization, chronic pain</li>
<li>Pontine lesion → impaired voluntary gait initiation</li>
</ul>
</div>
<div class="drug-box">
<div class="box-title">💊 Drugs</div>
<ul>
<li><b>SNRIs (duloxetine, venlafaxine)</b>: Augment descending noradrenergic/serotonergic reticulospinal inhibition; treat neuropathic pain</li>
<li><b>TCAs (amitriptyline)</b>: Block NE/5-HT reuptake in descending inhibitory pathway</li>
<li><b>Nifedipine / GTN</b>: For acute autonomic dysreflexia hypertensive crisis</li>
<li><b>Alpha blockers (tamsulosin, prazosin)</b>: Manage chronic autonomic dysreflexia</li>
<li><b>Opioids</b>: Activate descending inhibitory system (PAG-reticulospinal axis)</li>
</ul>
</div>
</div>
</div>
<!-- COMPARISON TABLE -->
<table class="comparison-table">
<tr>
<th>Tract</th><th>Origin</th><th>Decussation</th><th>Location in Cord</th><th>Function</th><th>Lesion Sign</th>
</tr>
<tr>
<td><b>Lateral Corticospinal</b></td>
<td>Motor cortex</td>
<td>Pyramidal decussation (caudal medulla) — CONTRALATERAL</td>
<td>Lateral funiculus</td>
<td>Voluntary limb movement</td>
<td>Ipsilateral UMN spastic weakness (in cord lesion)</td>
</tr>
<tr>
<td><b>Rubrospinal</b></td>
<td>Red nucleus (midbrain)</td>
<td>Ventral tegmental decussation — CONTRALATERAL</td>
<td>Lateral funiculus (cervical)</td>
<td>Flexion of upper limb</td>
<td>Contralateral arm ataxia (with red nucleus lesion)</td>
</tr>
<tr>
<td><b>Anterior Corticospinal</b></td>
<td>Motor cortex</td>
<td>Segmental — BILATERAL</td>
<td>Anterior funiculus</td>
<td>Axial/truncal muscles</td>
<td>Bilateral trunk weakness</td>
</tr>
<tr>
<td><b>Tectospinal</b></td>
<td>Superior colliculus</td>
<td>Dorsal tegmental decussation — BILATERAL</td>
<td>Near anterior median fissure (cervical)</td>
<td>Visual-guided head/neck reflexes</td>
<td>Loss of visual orienting reflex</td>
</tr>
<tr>
<td><b>Vestibulospinal (Lateral)</b></td>
<td>Lateral vestibular nucleus</td>
<td>IPSILATERAL — does not cross</td>
<td>Anterior funiculus (entire cord)</td>
<td>Facilitates extensors; maintains balance</td>
<td>Ipsilateral postural instability</td>
</tr>
<tr>
<td><b>Reticulospinal</b></td>
<td>Pontine/medullary reticular formation</td>
<td>Ipsilateral (mainly)</td>
<td>Anterior funiculus</td>
<td>Voluntary movement, autonomic outflow, pain inhibition</td>
<td>Autonomic dysreflexia, loss of pain modulation</td>
</tr>
</table>
<footer>Source: Gray's Anatomy for Students (Elsevier 2023) · Adams & Victor's Principles of Neurology · Katzung's Pharmacology · Goldman-Cecil Medicine</footer>
</body>
</html>
~/spinal-tracts/syndromes_treatment.html
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Spinal Cord Syndromes — Tracts, Deficits & Treatment</title>
<style>
* { box-sizing: border-box; margin: 0; padding: 0; }
body { font-family: 'Segoe UI', Arial, sans-serif; background: #eceff1; padding: 28px; }
h1 { text-align: center; color: #1a237e; font-size: 26px; margin-bottom: 5px; }
.subtitle { text-align: center; color: #546e7a; font-size: 13px; margin-bottom: 28px; }
/* ── SYNDROME CARDS ── */
.grid { display: flex; flex-wrap: wrap; gap: 22px; justify-content: center; margin-bottom: 36px; }
.card {
background: white; border-radius: 14px;
box-shadow: 0 4px 16px rgba(0,0,0,0.11);
width: 350px; overflow: hidden; padding-bottom: 14px;
}
.card-header {
padding: 13px 16px; color: white; font-size: 14px; font-weight: 700;
text-align: center; letter-spacing: 0.5px;
}
.h-brown { background: linear-gradient(135deg,#4e342e,#795548); }
.h-ant { background: linear-gradient(135deg,#b71c1c,#e53935); }
.h-central { background: linear-gradient(135deg,#1565c0,#1e88e5); }
.h-post { background: linear-gradient(135deg,#2e7d32,#43a047); }
.h-complete{ background: linear-gradient(135deg,#37474f,#607d8b); }
.h-scd { background: linear-gradient(135deg,#6a1b9a,#8e24aa); }
.h-syringo { background: linear-gradient(135deg,#e65100,#ff7043); }
.row { display: flex; gap: 10px; margin: 9px 13px 0 13px; }
.col { flex: 1; }
.mini-box {
border-radius: 7px; padding: 8px 10px; font-size: 11.5px; height: 100%;
}
.mini-box .mtitle { font-weight: 700; font-size: 10.5px; text-transform: uppercase; letter-spacing: 0.4px; margin-bottom: 4px; }
.mini-box ul { padding-left: 12px; }
.mini-box li { margin-bottom: 2px; line-height: 1.4; }
.box-cause { background: #e3f2fd; border-left: 3px solid #2196f3; }
.box-tracts { background: #f3e5f5; border-left: 3px solid #9c27b0; }
.box-deficits{ background: #fff8e1; border-left: 3px solid #ffc107; }
.box-spared { background: #e8f5e9; border-left: 3px solid #4caf50; }
.box-rx { background: #fce4ec; border-left: 3px solid #e91e63; }
.diagram-box {
margin: 10px 13px 0 13px;
background: #37474f; border-radius: 8px;
padding: 10px;
font-size: 11px; color: white;
text-align: center;
font-family: monospace;
line-height: 1.6;
}
.diagram-box .dtitle { font-size: 11.5px; font-weight: 700; margin-bottom: 6px; color: #80cbc4; letter-spacing: 0.5px; }
.tag-loss { color: #ff8a80; font-weight: 700; }
.tag-pres { color: #69f0ae; font-weight: 700; }
.tag-side { font-style: italic; color: #ffcc02; }
/* ── MASTER COMPARISON TABLE ── */
.comp-section { margin: 0 0 30px 0; }
.comp-section h2 { text-align: center; color: #1a237e; font-size: 18px; margin-bottom: 14px; }
.comp-table { width: 100%; border-collapse: collapse; font-size: 11.5px; }
.comp-table th { background: #1a237e; color: white; padding: 9px 10px; text-align: left; }
.comp-table td { padding: 7px 10px; border: 1px solid #cfd8dc; vertical-align: top; }
.comp-table tr:nth-child(even) td { background: #f5f5f5; }
.comp-table tr:hover td { background: #e8eaf6; }
.pill { display: inline-block; border-radius: 10px; padding: 1px 7px; font-size: 10.5px; font-weight: 700; white-space: nowrap; margin: 1px; }
.p-loss { background: #ef9a9a; color: #b71c1c; }
.p-pres { background: #a5d6a7; color: #1b5e20; }
.p-ipsi { background: #90caf9; color: #0d47a1; }
.p-contra { background: #ef9a9a; color: #b71c1c; }
.p-bilat { background: #fff176; color: #f57f17; }
/* ── DRUG MASTER TABLE ── */
.drug-section { margin-bottom: 30px; }
.drug-section h2 { text-align: center; color: #1a237e; font-size: 18px; margin-bottom: 14px; }
.drug-table { width: 100%; border-collapse: collapse; font-size: 11.5px; }
.drug-table th { background: #4a148c; color: white; padding: 9px 10px; text-align: left; }
.drug-table td { padding: 7px 10px; border: 1px solid #cfd8dc; vertical-align: top; }
.drug-table tr:nth-child(even) td { background: #f3e5f5; }
footer { text-align: center; margin-top: 24px; color: #90a4ae; font-size: 11px; }
</style>
</head>
<body>
<h1>SPINAL CORD SYNDROMES</h1>
<p class="subtitle">Tracts Affected · Deficit Pattern · Spared Functions · Treatment</p>
<div class="grid">
<!-- BROWN-SÉQUARD -->
<div class="card">
<div class="card-header h-brown">BROWN-SÉQUARD SYNDROME (Cord Hemisection)</div>
<div class="diagram-box">
<div class="dtitle">CROSS-SECTION DIAGRAM</div>
<span class="tag-loss">▓▓▓</span> = DAMAGED (LEFT half shown)<br>
<span class="tag-pres">░░░</span> = INTACT<br><br>
┌──────────────────────┐<br>
│ <span class="tag-loss">DC (ipsi) LCST (ipsi)</span> │<br>
│ <span class="tag-pres">░░ STT intact (contra) ░░</span> │<br>
└──────────────────────┘<br>
<span class="tag-side">Left hemisection = Left motor + proprioception loss; Right pain/temp loss</span>
</div>
<div class="row">
<div class="col"><div class="mini-box box-cause">
<div class="mtitle">Common Causes</div>
<ul><li>Penetrating trauma (stabbing)</li><li>Tumour (extradural/intradural)</li><li>Multiple sclerosis plaque</li><li>Disc herniation</li></ul>
</div></div>
<div class="col"><div class="mini-box box-tracts">
<div class="mtitle">Tracts Damaged</div>
<ul>
<li>Ipsilateral LCST</li>
<li>Ipsilateral Dorsal Columns</li>
<li>Contralateral STT (crosses early)</li>
</ul>
</div></div>
</div>
<div class="row">
<div class="col"><div class="mini-box box-deficits">
<div class="mtitle">Deficits</div>
<ul>
<li><b>Ipsilateral</b>: UMN spastic weakness, loss of proprioception + vibration (below lesion)</li>
<li><b>Contralateral</b>: Loss of pain + temperature (1–2 levels below)</li>
<li>At lesion level: Ipsilateral LMN weakness + ipsilateral analgesia (segmental)</li>
</ul>
</div></div>
<div class="col"><div class="mini-box box-rx">
<div class="mtitle">Treatment</div>
<ul>
<li>High-dose IV methylprednisolone (acute SCI)</li>
<li>Surgical decompression if compressive</li>
<li>Baclofen / tizanidine for spasticity</li>
<li>Rehabilitation physiotherapy</li>
<li><b>Best prognosis</b> of all incomplete SCI</li>
</ul>
</div></div>
</div>
</div>
<!-- ANTERIOR CORD SYNDROME -->
<div class="card">
<div class="card-header h-ant">ANTERIOR CORD SYNDROME</div>
<div class="diagram-box">
<div class="dtitle">CROSS-SECTION DIAGRAM</div>
<span class="tag-loss">▓ = Damaged </span> <span class="tag-pres">░ = Spared</span><br><br>
┌──────────────────────┐<br>
│ <span class="tag-pres">░░ Dorsal Columns ░░░</span> │ ← SPARED<br>
│ <span class="tag-loss">▓ LCST bilateral ▓</span> │ ← LOST<br>
│ <span class="tag-loss">▓ STT bilateral ▓</span> │ ← LOST<br>
└──────────────────────┘<br>
<span class="tag-side">Anterior spinal artery territory</span>
</div>
<div class="row">
<div class="col"><div class="mini-box box-cause">
<div class="mtitle">Common Causes</div>
<ul><li>Anterior spinal artery occlusion</li><li>Aortic surgery / dissection</li><li>Hyperflexion injury (C-spine)</li><li>Disc herniation (central)</li></ul>
</div></div>
<div class="col"><div class="mini-box box-tracts">
<div class="mtitle">Tracts Damaged</div>
<ul>
<li>Bilateral LCST (corticospinal)</li>
<li>Bilateral STT (spinothalamic)</li>
<li>Anterior horn cells (LMN at level)</li>
</ul>
</div></div>
</div>
<div class="row">
<div class="col"><div class="mini-box box-deficits">
<div class="mtitle">Deficits</div>
<ul>
<li>Bilateral <b>UMN motor weakness/paralysis</b> below lesion</li>
<li>Bilateral <b>loss of pain + temperature</b> below lesion</li>
<li>LMN weakness at the level of lesion</li>
<li><b>Autonomic dysfunction</b> (bladder/bowel)</li>
</ul>
</div></div>
<div class="col"><div class="mini-box box-spared">
<div class="mtitle">SPARED</div>
<ul>
<li>Proprioception ✓</li>
<li>Vibration ✓</li>
<li>Fine touch ✓</li>
<li>(Dorsal columns intact)</li>
</ul>
</div></div>
</div>
<div class="row">
<div class="col"><div class="mini-box box-rx">
<div class="mtitle">Treatment</div>
<ul>
<li>Reperfusion: anticoagulation / thrombolytics (ischaemic cause)</li>
<li>Surgical decompression (compressive)</li>
<li>Baclofen, tizanidine (spasticity)</li>
<li>Bladder management: catheterisation</li>
<li><b>Poor prognosis</b> for motor recovery</li>
</ul>
</div></div>
</div>
</div>
<!-- CENTRAL CORD SYNDROME -->
<div class="card">
<div class="card-header h-central">CENTRAL CORD SYNDROME</div>
<div class="diagram-box">
<div class="dtitle">CROSS-SECTION DIAGRAM</div>
Central grey matter + inner cord damaged<br><br>
┌──────────────────────┐<br>
│ <span class="tag-pres">░░ Outer LCST (legs) ░░</span> │ ← relatively SPARED<br>
│ <span class="tag-loss">▓▓ Central LCST (arms) ▓▓</span> │ ← DAMAGED (cervical fibers central)<br>
│ <span class="tag-loss">▓▓ Crossing STT fibers ▓▓</span> │<br>
└──────────────────────┘<br>
<span class="tag-side">Arms > Legs weakness (somatotopic LCST)</span>
</div>
<div class="row">
<div class="col"><div class="mini-box box-cause">
<div class="mtitle">Common Causes</div>
<ul><li>Hyperextension injury (elderly with spondylosis)</li><li>Syringomyelia</li><li>Intramedullary tumour</li><li>AVM / haematomyelia</li></ul>
</div></div>
<div class="col"><div class="mini-box box-tracts">
<div class="mtitle">Tracts Damaged</div>
<ul>
<li>Central LCST (cervical/arm fibers)</li>
<li>Central anterior horn</li>
<li>Crossing STT fibers (anterior commissure)</li>
</ul>
</div></div>
</div>
<div class="row">
<div class="col"><div class="mini-box box-deficits">
<div class="mtitle">Deficits</div>
<ul>
<li><b>Arms > Legs</b> weakness (UMN)</li>
<li>Bilateral pain/temp loss at lesion level (suspended)</li>
<li><b>Bladder dysfunction</b> (urinary retention)</li>
<li>Variable sensory loss below</li>
</ul>
</div></div>
<div class="col"><div class="mini-box box-rx">
<div class="mtitle">Treatment</div>
<ul>
<li>Immobilisation (cervical collar)</li>
<li>Surgical decompression (controversial timing)</li>
<li>Steroids: methylprednisolone (within 8h, disputed)</li>
<li>Antispastics: Baclofen, tizanidine</li>
<li>Bladder: catheterisation, oxybutynin</li>
<li><b>Most common incomplete SCI</b></li>
</ul>
</div></div>
</div>
</div>
<!-- POSTERIOR CORD SYNDROME -->
<div class="card">
<div class="card-header h-post">POSTERIOR CORD SYNDROME</div>
<div class="diagram-box">
<div class="dtitle">CROSS-SECTION DIAGRAM</div>
<span class="tag-loss">▓ = Damaged </span> <span class="tag-pres">░ = Spared</span><br><br>
┌──────────────────────┐<br>
│ <span class="tag-loss">▓▓▓ Dorsal Columns ▓▓▓</span> │ ← LOST<br>
│ <span class="tag-pres">░░ LCST intact ░░░░░</span> │ ← SPARED<br>
│ <span class="tag-pres">░░ STT intact ░░░░░░</span> │ ← SPARED<br>
└──────────────────────┘<br>
<span class="tag-side">Rare; posterior spinal artery territory</span>
</div>
<div class="row">
<div class="col"><div class="mini-box box-cause">
<div class="mtitle">Common Causes</div>
<ul><li>Posterior spinal artery occlusion (rare)</li><li>Vitamin B12 deficiency</li><li>Tabes dorsalis (neurosyphilis)</li><li>Multiple sclerosis</li></ul>
</div></div>
<div class="col"><div class="mini-box box-tracts">
<div class="mtitle">Tracts Damaged</div>
<ul>
<li>Bilateral Dorsal Columns (gracilis + cuneatus)</li>
<li>LCST and STT spared</li>
</ul>
</div></div>
</div>
<div class="row">
<div class="col"><div class="mini-box box-deficits">
<div class="mtitle">Deficits</div>
<ul>
<li>Bilateral loss of proprioception + vibration + fine touch</li>
<li><b>Sensory ataxia</b> (Romberg +ve — eyes closed)</li>
<li>Lhermitte's sign (MS)</li>
<li>"Stamping gait" (tabes dorsalis)</li>
</ul>
</div></div>
<div class="col"><div class="mini-box box-spared">
<div class="mtitle">SPARED</div>
<ul>
<li>Motor power ✓</li>
<li>Pain sensation ✓</li>
<li>Temperature ✓</li>
</ul>
</div></div>
</div>
<div class="row">
<div class="col"><div class="mini-box box-rx">
<div class="mtitle">Treatment</div>
<ul>
<li><b>B12 deficiency</b>: IM hydroxocobalamin (B12 injections)</li>
<li><b>Tabes dorsalis</b>: IV Benzylpenicillin (neurosyphilis)</li>
<li><b>MS</b>: Disease-modifying therapy (interferon-β, natalizumab, ocrelizumab)</li>
<li>Physiotherapy: balance training, gait rehabilitation</li>
</ul>
</div></div>
</div>
</div>
<!-- SUBACUTE COMBINED DEGENERATION -->
<div class="card">
<div class="card-header h-scd">SUBACUTE COMBINED DEGENERATION (SCD)</div>
<div class="diagram-box">
<div class="dtitle">CROSS-SECTION DIAGRAM</div>
<span class="tag-loss">▓ = Damaged </span> <span class="tag-pres">░ = Spared</span><br><br>
┌──────────────────────┐<br>
│ <span class="tag-loss">▓▓▓ Dorsal Columns ▓▓▓</span> │ ← DEMYELINATED<br>
│ <span class="tag-loss">▓▓▓ LCST (lateral) ▓▓▓</span> │ ← DEMYELINATED<br>
│ <span class="tag-pres">░░ STT intact ░░░░░░</span> │ ← SPARED (usually)<br>
└──────────────────────┘<br>
<span class="tag-side">"Combined" = Dorsal + Lateral columns both affected</span>
</div>
<div class="row">
<div class="col"><div class="mini-box box-cause">
<div class="mtitle">Cause</div>
<ul>
<li><b>Vitamin B12 deficiency</b> (most common)</li>
<li>Nitrous oxide abuse (inactivates B12)</li>
<li>Pernicious anaemia</li>
<li>Strict veganism</li>
<li>Gastric surgery / malabsorption</li>
</ul>
</div></div>
<div class="col"><div class="mini-box box-tracts">
<div class="mtitle">Tracts Damaged</div>
<ul>
<li>Dorsal columns (fasciculus gracilis + cuneatus)</li>
<li>Lateral corticospinal tracts (both sides)</li>
<li>Peripheral nerves also affected</li>
</ul>
</div></div>
</div>
<div class="row">
<div class="col"><div class="mini-box box-deficits">
<div class="mtitle">Deficits</div>
<ul>
<li>Loss of proprioception + vibration (dorsal columns)</li>
<li><b>Romberg +ve</b>; sensory ataxia</li>
<li>Spastic paraparesis + UMN signs (LCST)</li>
<li>Peripheral neuropathy (glove-stocking)</li>
<li>Macrocytic megaloblastic anaemia</li>
<li>Psychiatric: depression, dementia</li>
</ul>
</div></div>
<div class="col"><div class="mini-box box-rx">
<div class="mtitle">Treatment</div>
<ul>
<li><b>IM Hydroxocobalamin</b>: 1mg every other day × 2 wks, then monthly</li>
<li>Folic acid (ONLY after B12 — folic acid alone worsens neurological signs)</li>
<li>Physiotherapy for balance + spasticity</li>
<li>Baclofen for spasticity if present</li>
<li><b>Neurological recovery depends on duration</b> — treat early</li>
</ul>
</div></div>
</div>
</div>
<!-- SYRINGOMYELIA -->
<div class="card">
<div class="card-header h-syringo">SYRINGOMYELIA</div>
<div class="diagram-box">
<div class="dtitle">CROSS-SECTION DIAGRAM</div>
Central canal fluid-filled cavity (syrinx) expands outward<br><br>
┌──────────────────────┐<br>
│ <span class="tag-pres">░░░ Dorsal Columns ░░░</span> │ ← SPARED (early)<br>
│ <span class="tag-loss">▓▓ Anterior commissure ▓▓</span> │ ← FIRST DAMAGED<br>
│ <span class="tag-loss">▓▓ Ant. horn cells ▓▓▓</span> │ ← LMN affected<br>
│ → If expands: LCST damaged too<br>
└──────────────────────┘<br>
<span class="tag-side">"Cape distribution" bilateral pain/temp loss</span>
</div>
<div class="row">
<div class="col"><div class="mini-box box-cause">
<div class="mtitle">Causes</div>
<ul>
<li>Chiari I malformation (most common)</li>
<li>Post-traumatic</li>
<li>Arachnoiditis / tethered cord</li>
<li>Intramedullary tumour</li>
</ul>
</div></div>
<div class="col"><div class="mini-box box-tracts">
<div class="mtitle">Tracts Damaged</div>
<ul>
<li>Anterior commissure (crossing STT fibers) — first</li>
<li>Anterior horn cells</li>
<li>LCST (if syrinx enlarges)</li>
<li>Dorsal columns — spared early</li>
</ul>
</div></div>
</div>
<div class="row">
<div class="col"><div class="mini-box box-deficits">
<div class="mtitle">Deficits</div>
<ul>
<li><b>Bilateral</b> loss of pain + temperature in "cape" (shoulders/arms)</li>
<li>LMN weakness in upper limbs (hand wasting)</li>
<li>UMN signs in lower limbs (if expands)</li>
<li>Horner's syndrome (if sympathetics involved)</li>
<li><b>Dissociated sensory loss</b>: pain/temp lost; touch/proprioception preserved</li>
</ul>
</div></div>
<div class="col"><div class="mini-box box-rx">
<div class="mtitle">Treatment</div>
<ul>
<li>Treat underlying cause (e.g., Chiari decompression — suboccipital craniectomy)</li>
<li>Syrinx shunting/drainage (refractory cases)</li>
<li>Neuropathic pain: Gabapentin, pregabalin, amitriptyline</li>
<li>Physiotherapy</li>
<li>Regular MRI monitoring</li>
</ul>
</div></div>
</div>
</div>
</div>
<!-- MASTER COMPARISON TABLE -->
<div class="comp-section">
<h2>MASTER COMPARISON: All Spinal Cord Syndromes</h2>
<table class="comp-table">
<tr>
<th>Syndrome</th>
<th>Tracts Damaged</th>
<th>Motor</th>
<th>Pain / Temp (STT)</th>
<th>Proprioception / Vibration (DC)</th>
<th>Prognosis</th>
<th>Key Treatment</th>
</tr>
<tr>
<td><b>Brown-Séquard</b><br>(hemisection)</td>
<td>Ipsilateral LCST, DC; Contralateral STT</td>
<td><span class="pill p-ipsi">Ipsilateral</span> UMN weakness</td>
<td><span class="pill p-contra">Contralateral</span> loss (1–2 levels below)</td>
<td><span class="pill p-ipsi">Ipsilateral</span> loss</td>
<td>Best of incomplete SCI</td>
<td>Decompression, methylprednisolone, baclofen</td>
</tr>
<tr>
<td><b>Anterior Cord</b></td>
<td>Bilateral LCST + STT; anterior horn cells</td>
<td><span class="pill p-bilat">Bilateral</span> UMN weakness + LMN at level</td>
<td><span class="pill p-bilat">Bilateral</span> loss</td>
<td><span class="pill p-pres">PRESERVED</span></td>
<td>Poor motor recovery</td>
<td>Reperfusion, baclofen, bladder catheter</td>
</tr>
<tr>
<td><b>Central Cord</b></td>
<td>Central LCST (arm fibers), crossing STT, anterior horn</td>
<td>Arms >> Legs weakness <span class="pill p-bilat">Bilateral</span></td>
<td>Bilateral loss at level (suspended)</td>
<td>Variable</td>
<td>Good (legs recover first)</td>
<td>Immobilise, decompression, steroids, baclofen</td>
</tr>
<tr>
<td><b>Posterior Cord</b></td>
<td>Bilateral dorsal columns only</td>
<td><span class="pill p-pres">PRESERVED</span></td>
<td><span class="pill p-pres">PRESERVED</span></td>
<td><span class="pill p-bilat">Bilateral</span> loss; sensory ataxia; Romberg +</td>
<td>Good if cause treated</td>
<td>B12, penicillin (syphilis), DMT (MS)</td>
</tr>
<tr>
<td><b>Subacute Combined Degeneration</b></td>
<td>Bilateral DC + bilateral LCST</td>
<td><span class="pill p-bilat">Bilateral</span> spastic weakness (UMN)</td>
<td>Usually preserved</td>
<td><span class="pill p-bilat">Bilateral</span> loss + peripheral neuropathy</td>
<td>Good if treated early</td>
<td>IM Hydroxocobalamin (B12)</td>
</tr>
<tr>
<td><b>Syringomyelia</b></td>
<td>Anterior commissure (STT crossing), anterior horn, ± LCST</td>
<td>LMN hands, UMN legs (late)</td>
<td><span class="pill p-bilat">Bilateral</span> cape-like loss (dissociated)</td>
<td><span class="pill p-pres">PRESERVED</span> (early)</td>
<td>Variable (stops with treatment)</td>
<td>Chiari decompression, gabapentin (pain)</td>
</tr>
<tr>
<td><b>Complete Cord Transection</b></td>
<td>All tracts bilaterally</td>
<td>Flaccid → spastic <span class="pill p-bilat">Bilateral</span> paralysis</td>
<td><span class="pill p-bilat">Bilateral</span> loss</td>
<td><span class="pill p-bilat">Bilateral</span> loss</td>
<td>Very poor below lesion</td>
<td>Acute: methylprednisolone; Rehab; baclofen, anti-dysreflexia</td>
</tr>
</table>
</div>
<!-- DRUG MASTER TABLE -->
<div class="drug-section">
<h2>MASTER DRUG TABLE — Spinal Cord Tracts & Syndromes</h2>
<table class="drug-table">
<tr>
<th>Drug / Class</th>
<th>Mechanism</th>
<th>Tract / Pathway Target</th>
<th>Clinical Use</th>
</tr>
<tr>
<td><b>Morphine / Opioids</b><br>(systemic, intrathecal, epidural)</td>
<td>μ-receptor agonist (Gi-coupled) → ↓ cAMP, ↑ K⁺ efflux, ↓ Ca²⁺ influx</td>
<td>Dorsal horn (STT synapse) + PAG (spinomesencephalic) + Reticulospinal descending inhibition</td>
<td>Acute pain, cancer pain, epidural analgesia</td>
</tr>
<tr>
<td><b>Gabapentin / Pregabalin</b></td>
<td>Block α2δ subunit of voltage-gated Ca²⁺ channels → ↓ Substance P + glutamate release</td>
<td>STT dorsal horn (pre-synaptic)</td>
<td>Neuropathic pain, syringomyelia, post-SCI pain</td>
</tr>
<tr>
<td><b>Ketamine</b></td>
<td>NMDA receptor antagonist → blocks central sensitisation ("wind-up")</td>
<td>STT dorsal horn (post-synaptic NMDA receptors)</td>
<td>Refractory neuropathic pain, procedural analgesia</td>
</tr>
<tr>
<td><b>Local Anesthetics</b><br>(bupivacaine, lidocaine)</td>
<td>Block voltage-gated Na⁺ channels → prevent AP propagation; differential block (C-fibers first)</td>
<td>Spinal: all tracts at level; Epidural: STT (low dose) → LCST (high dose)</td>
<td>Spinal/epidural anaesthesia, labour analgesia</td>
</tr>
<tr>
<td><b>Baclofen</b><br>(oral/intrathecal)</td>
<td>GABA-B agonist → Gi-coupled; ↓ excitatory NT release; hyperpolarises motor interneurons</td>
<td>LCST / spinal cord interneurons (anterior horn)</td>
<td>Spasticity from SCI, MS, stroke; intrathecal for severe cases</td>
</tr>
<tr>
<td><b>Tizanidine</b></td>
<td>α2-adrenoceptor agonist → ↓ excitatory interneuron activity in spinal cord</td>
<td>LCST / reticulospinal descending inhibition</td>
<td>Spasticity (LCST lesion); also analgesia</td>
</tr>
<tr>
<td><b>Diazepam</b></td>
<td>GABA-A positive allosteric modulator → ↑ Cl⁻ influx; pre-synaptic inhibition in cord (α2-GABA-A)</td>
<td>LCST spinal cord interneurons</td>
<td>Spasticity, muscle spasm</td>
</tr>
<tr>
<td><b>Dantrolene</b></td>
<td>Blocks ryanodine receptor → ↓ Ca²⁺ from SR → ↓ muscle contraction</td>
<td>Muscle (not cord tracts) — acts peripherally</td>
<td>Severe spasticity, malignant hyperthermia, NMS</td>
</tr>
<tr>
<td><b>Duloxetine / SNRIs</b></td>
<td>Inhibit NE + 5-HT reuptake → augment descending inhibitory reticulospinal pathway</td>
<td>Reticulospinal descending pain modulation</td>
<td>Neuropathic pain, SCI pain, fibromyalgia</td>
</tr>
<tr>
<td><b>Hydroxocobalamin (B12)</b></td>
<td>Cofactor for myelin synthesis (methylmalonyl-CoA → succinyl-CoA); restores myelin</td>
<td>Dorsal columns + LCST (SCD repair)</td>
<td>Subacute combined degeneration, B12 deficiency</td>
</tr>
<tr>
<td><b>Methylprednisolone</b><br>(IV high dose)</td>
<td>↓ lipid peroxidation, ↓ oedema, ↓ inflammatory cytokines</td>
<td>All cord tracts (neuroprotection in acute SCI)</td>
<td>Acute traumatic SCI (within 8h; evidence controversial)</td>
</tr>
<tr>
<td><b>Nifedipine / GTN</b></td>
<td>Ca²⁺ channel blocker / NO donor → ↓ vasospasm + vasodilation</td>
<td>Autonomic (reticulospinal autonomic outflow)</td>
<td>Autonomic dysreflexia hypertensive crisis (T6 and above SCI)</td>
</tr>
</table>
</div>
<footer>Source: Gray's Anatomy for Students (Elsevier 2023) · Goldman-Cecil Medicine · Bradley & Daroff's Neurology · Goodman & Gilman's · Katzung's Pharmacology · Bailey & Love's Surgery</footer>
</body>
</html>
ls -lh /home/daytona/workspace/spinal-tracts/
| # | Flowchart | Contents | Download |
|---|---|---|---|
| 1 | Ascending Tracts | STT · DCML · Spinocerebellar — full 3-neuron pathway, decussation, clinical lesion signs, drugs | ascending tracts HTML File · HTML |
| 2 | Descending Tracts | LCST · Rubrospinal · ACST · Tectospinal · Vestibulospinal · Reticulospinal — origin, decussation, function, lesion signs, drugs | descending tracts HTML File · HTML |
| 3 | Syndromes + Treatment | Brown-Séquard · Anterior · Central · Posterior · SCD · Syringomyelia — cross-section diagrams, deficit tables, drug master table | syndromes treatment HTML File · HTML |